To further validate the potential functions of ITGB3 on osteosarcoma cell growth and migration in vitro, we used the CRISPR/Cas9‐mediated disruption system to generate the ITGB3‐knockout 143B cell line (Figure 2A). This evidence concerns the gene ITGB3 and osteosarcoma.